Korro Bio, Inc. (KRRO) is a biopharmaceutical company focused on developing RNA editing therapeutics. The company is in the development stage, working on drug candidates intended to treat rare diseases and other conditions. Korro Bio's pipeline involves proprietary RNA editing technology platforms. The company has not yet commercialized any products and is subject to FDA and comparable foreign regulatory oversight.
expected 2026-11-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-12 | 2025-12-31 | 0001193125-26-104156 | EDGAR | 102K words |
| 2025-03-18 | 2024-12-31 | 0000950170-25-040759 | EDGAR | 103K words |
| 2024-03-26 | 2023-12-31 | 0000950170-24-036396 | EDGAR | 122K words |
| 2023-03-10 | 2022-12-31 | 0000950170-23-007140 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0000950170-22-003655 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001564590-21-016117 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001564590-20-012977 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001193125-26-336707 | EDGAR | 62K words |
| 2025-11-12 | 2025-09-30 | 0001193125-25-277572 | EDGAR | 62K words |
| 2025-08-12 | 2025-06-30 | 0000950170-25-106912 | EDGAR | 61K words |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065800 | EDGAR | 58K words |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125362 | EDGAR | 64K words |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096189 | EDGAR | 63K words |
| 2024-05-14 | 2024-03-31 | 0000950170-24-059493 | EDGAR | 60K words |
| 2023-11-02 | 2023-09-30 | 0000950170-23-058171 | EDGAR | 21K words |
| 2023-08-10 | 2023-06-30 | 0000950170-23-041300 | EDGAR | 20K words |
| 2023-05-12 | 2023-03-31 | 0000950170-23-021755 | EDGAR | 54K words |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023231 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016072 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-19 | 0001193125-26-356877 | EDGAR | 1K words |
| 2026-08-06 | 0001193125-26-336685 | EDGAR | 3K words |
| 2026-03-12 | 0001193125-26-104135 | EDGAR | 3K words |
| 2026-03-09 | 0001193125-26-097575 | EDGAR | 1K words |
| 2026-01-27 | 0001193125-26-023436 | EDGAR | 3K words |
| 2026-01-15 | 0001193125-26-014087 | EDGAR | 1K words |
| 2025-12-18 | 0001193125-25-324795 | EDGAR | 8K words |
| 2025-11-12 | 0001193125-25-277556 | EDGAR | 3K words |
| 2025-10-08 | 0001193125-25-234001 | EDGAR | 9K words |
| 2025-08-12 | 0000950170-25-106910 | EDGAR | 3K words |
135 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001703647 |
| Ticker | KRRO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.korrobio.com |
| Listed | 2023-11-06 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/KRRO (~200 tokens, structured JSON with cryptographic provenance)